Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > All the Signs are Positive!!!

<< Previous

Bullboard Posts

Next >>

Comment by cote101on Jan 20, 2021 5:11pm

141 Views

Post# 32340262

RE:All the Signs are Positive!!!

SMOKEY1958 YOU SAVE THE CREDIBILITY OF THIS FORUM YOU ARE MY STAR NO 1- YOUR POST IS WHAT WE NEED TO READ HERE-BRAVO

Smokey1958 wrote:
As of market close today there is nothing to worry about and nothing required by those long on Thrm .....except a little patience. It seems impossible now to imagine a scenario that will reward investors with anything but a significantly positive return.

The following is a summary of a review I did this afternoon of the HC site.

* 117 tests are currently under HC review
* Of those, 20 are considered rapid (hours instead of days)
* Of those, only 8 are POC ....and ALL require either a blood or nasopharyngeal swab sample and a
health care professional to carry out the test.

There is NOTHING in the descriptions of these tests that would suggest they could be used on the massive scale governments require.

There is one, but is not quite ready for review .....CoviSafe. For you bashers and naysers this is not a pump .....follow the NRs, do your own review of the HC site and read the dozens of articles referring to the need ....all over the world. There is no other reasonable conclusion.

On the Frankfurt Exchange, Thrm finished at $.695 CAD, the OTC $.65 CAD

Morningstar's Fair Value so after market close yesterday was $1.01 and their speculative 1-star valuation, $10.57.